Back
Intellia Therapeutics Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
36
NTLA
Intellia Therapeutics
Last Price:
$8.52
Seasonality Move:
27.3%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.13 | Buy |
| 20-day SMA: | 8.23 | Buy |
| 50-day SMA: | 8.17 | Buy |
| 200-day SMA: | 14.24 | Sell |
| 8-day EMA: | 8.2 | Buy |
| 20-day EMA: | 8.12 | Buy |
| 50-day EMA: | 8.5 | Buy |
| 200-day EMA: | 13.7 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 53.64 | Buy |
| Chaikin Money Flow: | 2308661 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.5 - 8.58) | Buy |
| Bollinger Bands (100): | (7.82 - 11.14) | Sell |
Intellia Therapeutics Technical Analysis
| May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 8.50 while NTLA 8-day simple moving average is 8.13, which is a Buy signal.
-
The stock price of NTLA is 8.50 while Intellia Therapeutics 20-day SMA is 8.23, which makes it a Buy.
-
Intellia Therapeutics 50-day simple moving average is 8.17 while NTLA share price is 8.50, making it a Buy technically.
-
NTLA stock price is 8.50 and Intellia Therapeutics 200-day simple moving average is 14.24, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
36
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a SellThe current Intellia Therapeutics [NTLA] share price is $8.50. The Score for NTLA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
880.5M
Price in USD:
8.50
Share Volume:
2.5M
Intellia Therapeutics 52-Week Range
52-Week High:
28.18
52-Week Low:
5.90
Sell
36
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?The Intellia Therapeutics stock price is 8.50 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 8.50 while NTLA 8-day exponential moving average is 8.20, which is a Buy signal.
-
The stock price of NTLA is 8.50 while Intellia Therapeutics 20-day EMA is 8.12, which makes it a Buy.
-
Intellia Therapeutics 50-day exponential moving average is 8.50 while NTLA share price is 8.50, making it a Buy technically.
-
NTLA stock price is 8.50 and Intellia Therapeutics 200-day simple moving average is 13.70, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.08 per share, and an increase next year of $0.23 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Intellia Therapeutics is a Buy
-
Intellia Therapeutics Relative Strength Index (RSI) is 53.64, which suggest Intellia Therapeutics is overbought
-
The Bollinger Bands (25) for Intellia Therapeutics is (7.5 - 8.58), which suggest Intellia Therapeutics is a Sell
-
The Bollinger Bands (100) for Intellia Therapeutics is (7.82 - 11.14), which suggest Intellia Therapeutics is a Sell
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.